+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Ventricular Assist Device Market Size, Share & Trends Analysis Report By Product (LVAD, RVAD), By Type of Flow (Pulsatile, Continuous), By Application, By Region, And Segment Forecasts, 2019 - 2025

  • ID: 3640136
  • Report
  • 100 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • Abbott
  • Abiomed
  • Berlin Heart
  • CardiacAssist, Inc.
  • Jarvik Heart, Inc.
  • Medtronic
  • MORE
The global ventricular assist device market size is expected to reach USD 2,464.9 million by 2025, at a CAGR 11.4% over a forecast period, according to this report. Ventricular assist device (VAD) market is majorly driven by rising prevalence of heart failures, shortage of organ donors, and recent technological advancements improving the quality of lives of patients with weakened heart. HeartMate 3 LVAD by Abbott and EXCOR Pediatric LVAD by Berlin Heart are some of the examples of technologically advanced products.

Increasing number of research activities and new product launches are some of the major factors contributing to the market growth. Increasing number of new product approvals and recent technological advancements are anticipated to further fuel the demand. In addition, growing number of new product approvals are expected to further propel the demand in the forthcoming years. For instance, in 2018, Abbott has received U.S. Food and Drug Administration (FDA) approval for its HeartMate3 Left Ventricular Assist Device (LVAD) for patients with advanced heart failure. The key players contributing to the growth of the VAD market include Abbott, Medtronic, Berlin Heart, and ReliantHeart.

Ongoing clinical trials for testing of these devices and increased government funding are some of the factors that may positively impact the market over the forecast period. Growing patient awareness about the availability of these devices and increased R&D activities for new product development are projected to positively impact the market growth. Furthermore, rising cardiovascular diseases, improved healthcare infrastructure, and rise in healthcare expenditure propel the market growth in the developing countries.

Further key findings from the report suggest:
  • Left ventricular device segment is expected to register the fastest CAGR of 11.5% over the forecast period owing to increasing number of new product launches and ongoing research activities
  • Companies like Abbott are researching on newer technologies like magnetic levitation for smoother and pleasant experience with the device
  • Pulsatile flow ventricular assist devices are being replaced at a considerable rate as the continuously flow devices are safer and have lower wear and tear rate
  • Destination therapy is taking precedence over the other applications of ventricular assist devices, reason being the shortage of transplant organs and the promise of better quality of life
  • Advancements in the device safety and efficiency are pushing the adoption of VAD for long term instead of just as a bridge to transplant and candidacy
  • North America accounted for the largest revenue share in 2018 owing to rising prevalence of heart failures, high patient awareness, and shortage of heart donors
  • Asia Pacific is expected to emerge with the fastest CAGR of 12.0% over the forecast period
  • The ventricular assist device market is fairly competitive with the presence of key players such as Abbott, Medtronic, Berlin Heart, and ReliantHeart


Please Note: This report will be delivered within 2 business days of ordering.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • Abiomed
  • Berlin Heart
  • CardiacAssist, Inc.
  • Jarvik Heart, Inc.
  • Medtronic
  • MORE
Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Market definition
1.3. Information procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources & third party perspectives
1.4. Primary research
1.5. Information analysis
1.5.1. Data analysis models
1.6. Market formulation & data visualization
1.7. Data validation & publishing

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Ventricular Assist Devices, Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Pricing Analysis
3.4. Product Pipeline Analysis, by Stage
3.5. Industry Analysis
3.5.1. User perspective analysis
3.5.1.1. Consumer behavior analysis
3.5.1.2. Market influencer analysis
3.5.2. List of key end-users, by product
3.6. Technology Outlook
3.6.1. Technology timeline
3.7. Regulatory Framework
3.7.1. Reimbursement framework
3.7.2. Standards & compliance
3.7.3. Safety
3.8. Market Dynamics
3.8.1. Market driver analysis
3.8.1.1. Increasing prevalence of cardiovascular diseases
3.8.1.2. Technological advancements pertaining to novel product development
3.8.1.3. Shortage of transplant organs
3.8.2. Market restraint analysis
3.8.2.1. High procedure cost
3.8.2.2. Insurance coverage is limited in emerging countries
3.8.3. Industry challenges
3.8.3.1. Development of small, affordable and efficient devices
3.9. Ventricular Assist Devices Market Analysis Tools
3.9.1. Industry analysis - Porters
3.9.1.1. Supplier power
3.9.1.2. Buyer power
3.9.1.3. Substitute threat
3.9.1.4. New entrant threat
3.9.1.5. Competitive rivalry
3.9.2. PESTEL analysis
3.9.2.1. Political landscape
3.9.2.2. Environmental landscape
3.9.2.3. Social landscape
3.9.2.4. Technology landscape
3.9.2.5. Legal landscape
3.9.3. Major deals & strategic alliances analysis
3.9.3.1. Joint ventures
3.9.3.2. Mergers & acquisitions
3.9.3.3. Lincensing & partnerships
3.9.3.4. Technological collaborations
3.9.3.5. Strategic divestments
3.9.4. Market entry strategies
3.9.5. Case studies

Chapter 4. Ventricular Assist Device Market - Competitive Analysis
4.1. Recent Developments & Impact Analysis, By Key Market Participants
4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
4.3. Vendor Landscape
4.3.1. List of key distributors and channel partners
4.3.2. Key company market share analysis, 2018
4.4. Public Companies
4.4.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
4.4.2. Company market ranking, by region
4.5. Private Companies
4.5.1. List of key emerging companies /technology disruptors/innovators
4.5.2. Funding Outlook
4.5.3. Regional network map
4.5.4. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)

Chapter 5. Ventricular Assist Device Market: Product Estimates & Trend Analysis
5.1. Definitions & Scope
5.2. Product Market Share Analysis, 2018 & 2025
5.3. Segment Dashboard
5.4. Global Ventricular Assist Device, by Product, 2014 to 2025
5.4.1. Left ventricular assist device
5.4.1.1. Left venticular assist devices market revenue estimates and forecasts, 2014 - 2025 (USD Million)
5.4.1.2. Left venticular assist devices market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
5.4.2. Right Ventricular Assist Device
5.4.2.1. Right venticular assist devices market revenue estimates and forecasts, 2014 - 2025 (USD Million)
5.4.2.2. Right venticular assist devices market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)
5.4.3. Bi-Ventricular Assist Device
5.4.3.1. Bi venticular assist devices market revenue estimates and forecasts, 2014 - 2025 (USD Million)
5.4.3.2. Bi venticular assist devices market revenue estimates and forecasts, by application, 2014 - 2025 (USD Million)

Chapter 6. Ventricular Assist Device Market, Type of Flow Estimates & Trend Analysis
6.1. Definitions & Scope
6.2. Type of Flow Market Share Analysis, 2018 & 2025
6.3. Segment Dashboard
6.4. Global Ventricular Assist Device, by Type of Flow, 2014 to 2025
6.4.1. Pulsatile flow
6.4.1.1. Pulsatile flow devices market revenue estimates and forecasts, 2014 - 2025 (USD Million)
6.4.2. Continuous flow
6.4.2.1. Continuous flow devices market revenue estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 7. Ventricular Assist Device Market, Application Estimates & Trend Analysis
7.1. Definitions & Scope
7.2. Application Market Share Analysis, 2018 & 2025
7.3. Segment Dashboard
7.4. Global Ventricular Assist Devices, by Application, 2014 to 2025
7.4.1. Bridge to transplant
7.4.1.1. Bridge to transplant market revenue estimates and forecasts, 2014 - 2025 (USD Million)
7.4.2. Destination therapy
7.4.2.1. Destination therapy market revenue estimates and forecasts, 2014 - 2025 (USD Million)
7.4.3. Others
7.4.3.1. Other applications market revenue estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 8. Ventricular Assist Devices Market: Regional Estimates, by Product, Type of Flow, & Application
8.1. Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
8.1.1. North America
8.1.1.1. North America ventricular assist devices, by product, 2014 to 2025
8.1.1.2. North America ventricular assist devices, by type of flow, 2014 to 2025
8.1.1.3. North America ventricular assist devices, by application, 2014 to 2025
8.1.1.4. U.S.
8.1.1.4.1. U.S. ventricular assist devices, by product, 2014 to 2025
8.1.1.4.2. U.S. ventricular assist devices, by type of flow, 2014 to 2025
8.1.1.4.3. U.S. ventricular assist devices, by application, 2014 to 2025
8.1.1.5. Canada
8.1.1.5.1. Canada ventricular assist devices, by product, 2014 to 2025
8.1.1.5.2. Canada ventricular assist devices, by type of flow, 2014 to 2025
8.1.1.5.3. Canada ventricular assist devices, by application, 2014 to 2025
8.1.2. Europe
8.1.2.1. Europe ventricular assist devices, by product, 2014 to 2025
8.1.2.2. Europe ventricular assist devices, by type of flow, 2014 to 2025
8.1.2.3. Europe ventricular assist devices, by application, 2014 to 2025
8.1.2.4. Germany
8.1.2.4.1. Germany ventricular assist devices, by product, 2014 to 2025
8.1.2.4.2. Germany ventricular assist devices, by type of flow, 2014 to 2025
8.1.2.4.3. Germany ventricular assist devices, by application, 2014 to 2025
8.1.2.5. U.K.
8.1.2.5.1. U.K. ventricular assist devices, by product, 2014 to 2025
8.1.2.5.2. U.K. ventricular assist devices, by type of flow, 2014 to 2025
8.1.2.5.3. U.K. ventricular assist devices, by application, 2014 to 2025
8.1.2.6. France
8.1.2.6.1. France ventricular assist devices, by product, 2014 to 2025
8.1.2.6.2. France ventricular assist devices, by type of flow, 2014 to 2025
8.1.2.6.3. France ventricular assist devices, by application, 2014 to 2025
8.1.2.7. Spain
8.1.2.7.1. Spain ventricular assist devices, by product, 2014 to 2025
8.1.2.7.2. Spain ventricular assist devices, by type of flow, 2014 to 2025
8.1.2.7.3. Spain ventricular assist devices, by application, 2014 to 2025
8.1.2.8. Italy
8.1.2.8.1. Italy ventricular assist devices, by product, 2014 to 2025
8.1.2.8.2. Italy ventricular assist devices, by type of flow, 2014 to 2025
8.1.2.8.3. Italy ventricular assist devices, by application, 2014 to 2025
8.1.2.9. Russia
8.1.2.9.1. Russia ventricular assist devices, by product, 2014 to 2025
8.1.2.9.2. Russia ventricular assist devices, by type of flow, 2014 to 2025
8.1.2.9.3. Russia ventricular assist devices, by application, 2014 to 2025
8.1.3. Asia Pacific
8.1.3.1. Asia Pacific ventricular assist devices, by product, 2014 to 2025
8.1.3.2. Asia Pacific ventricular assist devices, by type of flow, 2014 to 2025
8.1.3.3. Asia Pacific ventricular assist devices, by application, 2014 to 2025
8.1.3.4. China
8.1.3.4.1. China ventricular assist devices, by product, 2014 to 2025
8.1.3.4.2. China ventricular assist devices, by type of flow, 2014 to 2025
8.1.3.4.3. China ventricular assist devices, by application, 2014 to 2025
8.1.3.5. Japan
8.1.3.5.1. Japan ventricular assist devices, by product, 2014 to 2025
8.1.3.5.2. Japan ventricular assist devices, by type of flow, 2014 to 2025
8.1.3.5.3. Japan ventricular assist devices, by application, 2014 to 2025
8.1.3.6. India
8.1.3.6.1. India ventricular assist devices, by product, 2014 to 2025
8.1.3.6.2. India ventricular assist devices, by type of flow, 2014 to 2025
8.1.3.6.3. India ventricular assist devices, by application, 2014 to 2025
8.1.3.7. South Korea
8.1.3.7.1. South Korea ventricular assist devices, by product, 2014 to 2025
8.1.3.7.2. South Korea ventricular assist devices, by type of flow, 2014 to 2025
8.1.3.7.3. South Korea ventricular assist devices, by application, 2014 to 2025
8.1.3.8. Singapore
8.1.3.8.1. Singapore ventricular assist devices, by product, 2014 to 2025
8.1.3.8.2. Singapore ventricular assist devices, by type of flow, 2014 to 2025
8.1.3.8.3. Singapore ventricular assist devices, by application, 2014 to 2025
8.1.3.9. Australia
8.1.3.9.1. Australia ventricular assist devices, by product, 2014 to 2025
8.1.3.9.2. Australia ventricular assist devices, by type of flow, 2014 to 2025
8.1.3.9.3. Australia ventricular assist devices, by application, 2014 to 2025
8.1.4. Latin America
8.1.4.1. Latin America ventricular assist devices, by product, 2014 to 2025
8.1.4.2. Latin America ventricular assist devices, by type of flow, 2014 to 2025
8.1.4.3. Latin America ventricular assist devices, by application, 2014 to 2025
8.1.4.4. Brazil
8.1.4.4.1. Brazil ventricular assist devices, by product, 2014 to 2025
8.1.4.4.2. Brazil ventricular assist devices, by type of flow, 2014 to 2025
8.1.4.4.3. Brazil ventricular assist devices, by application, 2014 to 2025
8.1.4.5. Mexico
8.1.4.5.1. Mexico ventricular assist devices, by product, 2014 to 2025
8.1.4.5.2. Mexico ventricular assist devices, by type of flow, 2014 to 2025
8.1.4.5.3. Mexico ventricular assist devices, by application, 2014 to 2025
8.1.4.6. Argentina
8.1.4.6.1. Argentina ventricular assist devices, by product, 2014 to 2025
8.1.4.6.2. Argentina ventricular assist devices, by type of flow, 2014 to 2025
8.1.4.6.3. Argentina ventricular assist devices, by application, 2014 to 2025
8.1.5. Middle East & Africa
8.1.5.1. MEA ventricular assist devices, by product, 2014 to 2025
8.1.5.2. MEA ventricular assist devices, by type of flow, 2014 to 2025
8.1.5.3. MEA ventricular assist devices, by application, 2014 to 2025
8.1.5.4. Saudi Arabia
8.1.5.4.1. Saudi Arabia ventricular assist devices, by product, 2014 to 2025
8.1.5.4.2. Saudi Arabia ventricular assist devices, by type of flow, 2014 to 2025
8.1.5.4.3. Saudi Arabia ventricular assist devices, by application, 2014 to 2025
8.1.5.5. South Africa
8.1.5.5.1. South Africa ventricular assist devices, by product, 2014 to 2025
8.1.5.5.2. South Africa ventricular assist devices, by type of flow, 2014 to 2025
8.1.5.5.3. South Africa ventricular assist devices, by application, 2014 to 2025
8.1.5.6. UAE
8.1.5.6.1. UAE ventricular assist devices, by product, 2014 to 2025
8.1.5.6.2. UAE ventricular assist devices, by type of flow, 2014 to 2025
8.1.5.6.3. UAE ventricular assist devices, by application, 2014 to 2025
8.2. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa

Chapter 9. Competitive Landscape
9.1. Company Profiles
9.1.1. Abiomed
9.1.1.1. Company overview
9.1.1.2. Financial performance
9.1.1.3. Product benchmarking
9.1.1.4. Strategic initiatives
9.1.2. Medtronic
9.1.2.1. Company overview
9.1.2.2. Financial performance
9.1.2.3. Product benchmarking
9.1.2.4. Strategic initiatives
9.1.3. Abbott
9.1.3.1. Company overview
9.1.3.2. Financial performance
9.1.3.3. Product benchmarking
9.1.3.4. Strategic initiatives
9.1.4. Berlin Heart
9.1.4.1. Company overview
9.1.4.2. Financial performance
9.1.4.3. Product benchmarking
9.1.4.4. Strategic initiatives
9.1.5. CardiacAssist, Inc.
9.1.5.1. Company overview
9.1.5.2. Financial performance
9.1.5.3. Product benchmarking
9.1.5.4. Strategic initiatives
9.1.6. Jarvik Heart, Inc.
9.1.6.1. Company overview
9.1.6.2. Financial performance
9.1.6.3. Product benchmarking
9.1.6.4. Strategic Initiatives
9.1.7. ReliantHeart, Inc.
9.1.7.1. Company overview
9.1.7.2. Financial performance
9.1.7.3. Product benchmarking
9.1.7.4. Strategic initiatives
9.1.8. Sun Medical Technology Research Corp.
9.1.8.1. Company overview
9.1.8.2. Financial performance
9.1.8.3. Product benchmarking
9.1.8.4. Strategic initiatives
9.2. List of other Companies

*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abiomed
  • Medtronic
  • Abbott
  • Berlin Heart
  • CardiacAssist, Inc.
  • Jarvik Heart, Inc.
  • ReliantHeart, Inc.
  • Sun Medical Technology Research Corp.
Note: Product cover images may vary from those shown
Adroll
adroll